Kim Forest Enterprise Co., Ltd. (TPE:6645)

Market Cap	788.11M -41.5%
Revenue (ttm)	549.14M +9.5%
Net Income	-146.45M
EPS	-2.41
Shares Out	60.62M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,881
Average Volume	50,775
Open	13.00
Previous Close	13.10
Day's Range	12.80 - 13.20
52-Week Range	12.80 - 26.45
Beta	0.19
RSI	33.33
Earnings Date	May 12, 2026

About Kim Forest Enterprise

Kim Forest Enterprise Co., Ltd. provides various genetic and medical testing services in China and the United States. The company provides genetic testing, drug report, and monitoring tools for cancer patients; and GoL Life that provides a non-invasive genome-wide health assessment for healthy persons. It offers bioinformatics service items; prenatal test kits; and genetically modified models. In addition, the company offers SARS-CoV-2 detection kits. Further, it engages in the wholesale of medical instruments and consumables; and provision of ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2004
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6645

Financial Performance

In 2025, Kim Forest Enterprise's revenue was 549.14 million, an increase of 9.49% compared to the previous year's 501.53 million. Losses were -146.45 million, -8.40% less than in 2024.